Is Elon's Empire Crumbling?
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Shares Stats
| Shares Outstanding | 141,940,000 |
| Shares Float | 125,420,000 |
| Shares Short | 9,130,000 |
| Insider Holdings | 561% |
| Institution Holdings | 65.42% |
About Applied Therapeutics Inc
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
General
| Name | Applied Therapeutics Inc |
| Ticker | APLT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 32 |
Highlights
| Analyst Target | 3.17 |
| Market Cap | 88,100,000 |
| EBITDA | -111,388,000 |
Financials
| Curr Year EPS Estimate | -0.57 |
| Next Quarter EPS Estimate | -0.14 |
| Profit Margin | -55523.77% |
| Operating Margin | -91,301.64 |
| Return on Assets | -0.84 |
| Return on Equity | -1.51 |
| Revenue | 120,000 |
| Earnings Per Share | -0.46 |
| Revenue Per Share | 0.00 |
| Gross Profit | -44,162,000 |
| Quarterly Revenue Growth | -0.98 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 1,475.83 |
| Price/Book (Most Recent Quarter) | 10.24 |
Earnings
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.
Tucker Carlson Asks OpenAI CEO Sam Altman If He Ordered Employee's Murder
During an interview with OpenAI CEO Sam Altman, Tucker Carlson suggested Altman may have played a role in the death of former employee Suchir Balaji.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
EU chief says it's time for Europe's 'independence moment' faced with war and major power tensions
BRUSSELS (AP) — The European Union’s most powerful official warned Wednesday that Europe is battling against a series of threats posed by Russia, new global and even other major world powers and must stake claim to its independence.
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Asian shares trade mixed after Wall Street sets new records
TOKYO (AP) — Asian shares traded mixed on Tuesday after Wall Street set new records as investor anticipation grew that the U.S. Federal Reserve will announce the first cut of the year on its main interest rate.
Crypto Is The Money For AI, Says Economist As Coinbase CEO Teases Stablecoin-Powered Transactions Between Agents
Renowned economist Alex Tabbarok described cryptocurrencies as the “money” for artificial intelligence on Tuesday after Coinbase Global Inc. (NASDAQ:COIN) CEO teased a new feature that enables AI agents to transact using stablecoins.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44. The company's market cap stands at $156.6 million.
These four electric SUVs provide hot-rod thrills without the need for gas
SUVs are undoubtedly practical, but they can often be a bore. What if you also want sporty performance from your family-hauler? Surprisingly, your best bet might just be an electric SUV. Thanks in part to the inherent advantages of EV powertrain design, hair-raising acceleration is no longer exclusive to low-slung exotics. Plus, many automakers are now making well-rounded performance SUVs that also provide improved handling, stronger braking and sportier aesthetics. Edmunds’ auto experts have rounded up four of their favorites. The vehicles are listed in ascending order of price, which include
Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad
Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.
Trump Tariffs To Push 875,000 Americans Into Poverty? Survey Sizes Up Economic Impact
A non-partisan research centers uses two methods to predict how many more people will fall into poverty in the United States due to tariffs.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Bitcoin Stalls Near $116,000 (Again): What Is Going On?
Bitcoin (CRYPTO: BTC) is cooling near $116,000 after its post-FOMC rally, with traders closely watching liquidity levels to gauge the next move.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Apple Services Revenue Trajectory Signals Softness With Weaker App Store Downloads: Analyst
Apple's App Store revenue and downloads grew in August, but at a slower pace than historical trends. JP Morgan analyst maintains Overweight rating.
Peter Schiff Blames Fannie Mae And Freddie Mac For Skyrocketing Home Prices: 'By Inflating Demand, They Jack Up Prices,' Leading To A 'Debt Trap'
Economist Peter Schiff criticized America's two most prominent housing finance institutions, blaming them for the current housing affordability crisis.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Bill Holdings Shares Soar On Elliott Management Stake: Is An Activist Battle Brewing?
Bill Holdings stock is trading higher with a new activist investor circling the company. Shareholders could find out if two activists are better than one.
Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact
UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
OpenAI reaches new agreement with Microsoft to change its corporate structure
OpenAI has reached a new tentative agreement with Microsoft and said its nonprofit, which technically controls its business, will now be given a $100 billion equity stake in its for-profit corporation.
FAA seeks $3.1 million in fines from Boeing over safety violations, 2024 midair panel blowout
The Federal Aviation Administration is seeking $3.1 million in fines from Boeing over safety violations, including ones related to an Alaska Airlines jetliner losing a door plug panel on its fuselage in midflight.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Shiba Inu's Layer-2 Network Breached, Over $1 Million Each in Ethereum, SHIB Stolen: How It Was Done
The Shiba Inu (CRYPTO: SHIB) team posted a detailed account of the hacking incident that impacted its ecosystem on Saturday, including details about the assets affected and subsequent actions taken.
UN agency appeals for funds to help tens of thousands of quake-hit Afghans, many still homeless
BRUSSELS (AP) — The U.N.'s migration agency is appealing for funds for around 134,000 people who need help in Afghanistan, nearly two weeks after an in the country’s mountainous east.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Elon Musk's $1 Trillion Pay Package Is 'A Little Bit Weird' To Compare Monetarily, Says Tesla Board Chair: It's About 'Voting Influence'
Tesla's board chair, Robyn Denholm, defended Elon Musk's $1 trillion compensation package, emphasizing its potential to drive unique performance despite recent sales struggles.
Tesla Faces Class Action Over 'Wage Theft' Amid Preference For H-1B Workers Following Elon Musk's Push To Optimize Visa Practice
Tesla is facing a federal class action lawsuit accusing it of favoring H-1B visa holders over U.S. workers to cut labor costs, even as the company battles financial headwinds and regulatory scrutiny.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Bitcoin Jumps On Cooler Inflation; Ethereum, XRP, Dogecoin Gain — Analysts See BTC Trading In This Range Until The Fed Meet
Leading cryptocurrencies rallied on Wednesday as U.S. producer inflation unexpectedly cooled, boosting the chances of interest rate cuts.
Eightco, Nebius, Quantumscape, Planet Labs And Globalstar: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average up 0.25% at 45,514.95, the S&P 500 advancing 0.2% to 6,495.15, and the Nasdaq climbing 0.45% to 21,798.69. These are the top stocks that gained the attention of retail traders and investors throughout the day.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost
On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) totaling $2.1 million. This follows Tempus AI's recent acquisition and mixed analyst ratings. Other key trades include purchases of Prime Medicine Inc (PRME) and Twist Bioscience Corp (TWST).
Trump's H-1B Visa Plan Stuns Big Tech, White House Says $100,000 Fee Is One-Time Only
The White House clarified that the $100,000 H-1B visa fee is a one-time charge, not an annual fee, amid confusion among major tech companies.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Scott Bessent Heads To Madrid For High-Stakes Talks With China As TikTok Deadline Looms, Tariff Pressures Escalate
U.S. Treasury Secretary Scott Bessent will meet Chinese Vice Premier He Lifeng in Madrid next week for high-stakes talks on tariffs, agriculture and TikTok's looming U.S. divestment deadline, as trade tensions deepen with Chinese exports to the U.S. plunging 33%.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.